[Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
Daito
K
K
Second Department of Internal Medicine, Tottori University School of Medicine.
Suou
T
T
Kawasaki
H
H
D015088:2',5'-Oligoadenylate Synthetase / Q000097:blood*; D000998:Antiviral Agents / Q000627:therapeutic use*; D001708:Biopterins / Q000031:analogs & derivatives* / Q000097:blood; D006526:Hepatitis C / Q000097:blood / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D019798:Neopterin; D016896:Treatment Outcome
D000998:Antiviral Agents; D001708:Biopterins; D019798:Neopterin; D007372:Interferons; D015088:2',5'-Oligoadenylate Synthetase